FIELD: pharmaceutical industry.
SUBSTANCE: method for carrying out affinity chromatography with the capture of immunoglobulin from the culture liquid includes the following steps: adding a water-soluble organic polymer that causes flocculation to the culture liquid, depth filtration and affinity chromatography of the filtrate of the resulting mixture, while the immunoglobulin is associated with the medium for affinity chromatography, then the medium for affinity chromatography is washed using a wash buffer of pH 5–9 and an ionic strength of 0.1–5 mol/l and eluting the immunoglobulin from the affinity chromatography resin using an elution buffer of pH 2.5–4.5, with a water-soluble organic polymer being a poly(diallyldimethylammonium chloride) with a molecular weight of 10-10,000 kDa, which is added at a final concentration of 0.01–1.0 w/v.%.
EFFECT: elimination of formation of a precipitate in affinity chromatography.
24 cl, 5 dwg, 19 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
FUSION PROTEIN PURIFICATION METHOD | 2015 |
|
RU2698654C2 |
CHROMATOGRAPHIC LIGAND | 2005 |
|
RU2541429C2 |
FULL FLOW-THROUGH PROCESS FOR PURIFYING RECOMBINANT PROTEINS | 2019 |
|
RU2792435C2 |
CHROMATOGRAPHIC LIGAND | 2005 |
|
RU2396246C2 |
ISOLATION AND PURIFICATION OF ANTI-IL-13 ANTIBODIES USING PROTEIN A AFFINITY CHROMATOGRAPHY | 2010 |
|
RU2603055C2 |
METHODS OF THE PROTEINS DOWNSTREAM PURIFICATION EFFICIENCY INCREASING WITH THE USE OF MEMBRANE ION EXCHANGE CHROMATOGRAPHY | 2012 |
|
RU2648999C2 |
CARRIER FOR AFFINE CHROMATOGRAPHY AND METHOD OF PURIFYING BIOLOGICAL SUBSTANCE | 2016 |
|
RU2694637C1 |
METHOD OF PURIFYING COAGULATION FACTOR VIII | 2009 |
|
RU2698392C2 |
METHOD FOR PURIFYING DIGLYCOSYLATED INTERFERON-BETA PROTEIN | 2020 |
|
RU2795430C1 |
METHOD FOR PURIFICATION OF BLOOD-COAGULATION FACTOR VIII | 2009 |
|
RU2567811C2 |
Authors
Dates
2023-04-18—Published
2020-03-25—Filed